| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case–Control Consortium (PanC4)
|
Lucenteforte, E.
|
|
|
23 |
2 |
p. 374-382
|
artikel
|
| 2 |
A meta-analysis of coffee consumption and pancreatic cancer
|
Turati, F.
|
|
|
23 |
2 |
p. 311-318
|
artikel
|
| 3 |
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk
|
Tramacere, I.
|
|
|
23 |
2 |
p. 287-297
|
artikel
|
| 4 |
A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group
|
Miller, K.D.
|
|
|
23 |
2 |
p. 331-337
|
artikel
|
| 5 |
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma
|
Zinzani, P.L.
|
|
|
23 |
2 |
p. 415-420
|
artikel
|
| 6 |
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study
|
Grignani, G.
|
|
|
23 |
2 |
p. 508-516
|
artikel
|
| 7 |
Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in Japan
|
Matsuo, K.
|
|
|
23 |
2 |
p. 479-490
|
artikel
|
| 8 |
Breast cancer subtypes and outcome after local and regional relapse
|
Montagna, E.
|
|
|
23 |
2 |
p. 324-331
|
artikel
|
| 9 |
Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes
|
Greco, F.A.
|
|
|
23 |
2 |
p. 298-304
|
artikel
|
| 10 |
Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study
|
Kotsakis, A.
|
|
|
23 |
2 |
p. 442-449
|
artikel
|
| 11 |
CMF revisited in the 21st century
|
Munzone, E.
|
|
|
23 |
2 |
p. 305-311
|
artikel
|
| 12 |
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma
|
Galsky, M.D.
|
|
|
23 |
2 |
p. 406-410
|
artikel
|
| 13 |
Dietary cholesterol intake and cancer
|
Hu, J.
|
|
|
23 |
2 |
p. 491-500
|
artikel
|
| 14 |
Does an organised screening programme reduce the inequalities in breast cancer survival?
|
Puliti, D.
|
|
|
23 |
2 |
p. 319-323
|
artikel
|
| 15 |
Editorial board
|
|
|
|
23 |
2 |
p. ii-iii
|
artikel
|
| 16 |
External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer
|
Kim, J.H.
|
|
|
23 |
2 |
p. 361-367
|
artikel
|
| 17 |
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
|
von Moos, R.
|
|
|
23 |
2 |
p. 531-536
|
artikel
|
| 18 |
Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network
|
Stacchiotti, S.
|
|
|
23 |
2 |
p. 501-508
|
artikel
|
| 19 |
Heine H. Hansen, 1938–2011: a European oncologist
|
Tonato, M.
|
|
|
23 |
2 |
p. 283-284
|
artikel
|
| 20 |
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
|
Rousseau, B.
|
|
|
23 |
2 |
p. 450-457
|
artikel
|
| 21 |
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation
|
Fountzilas, G.
|
|
|
23 |
2 |
p. 427-435
|
artikel
|
| 22 |
Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience
|
Khasraw, M.
|
|
|
23 |
2 |
p. 458-463
|
artikel
|
| 23 |
Lung cancer physicians’ referral practices for palliative care consultation
|
Smith, C.B.
|
|
|
23 |
2 |
p. 382-387
|
artikel
|
| 24 |
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome
|
Penel, N.
|
|
|
23 |
2 |
p. 517-523
|
artikel
|
| 25 |
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors
|
Soria, J.-C.
|
|
|
23 |
2 |
p. 463-471
|
artikel
|
| 26 |
Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience
|
Wozniak, A.
|
|
|
23 |
2 |
p. 353-360
|
artikel
|
| 27 |
Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection
|
Mya, D.H.T.
|
|
|
23 |
2 |
p. 421-426
|
artikel
|
| 28 |
Risk of second cancers in Waldenström macroglobulinemia
|
Varettoni, M.
|
|
|
23 |
2 |
p. 411-415
|
artikel
|
| 29 |
Screening mammography and socioeconomic inequalities in breast cancer survival
|
Woods, L.M.
|
|
|
23 |
2 |
p. 285-286
|
artikel
|
| 30 |
Second malignancies among Waldenstrom macroglobulinemia patients: small samples and sparse data
|
Ojha, R.P.
|
|
|
23 |
2 |
p. 542-543
|
artikel
|
| 31 |
Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers
|
Haan, J.C.
|
|
|
23 |
2 |
p. 367-374
|
artikel
|
| 32 |
Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry
|
Buchler, T.
|
|
|
23 |
2 |
p. 395-401
|
artikel
|
| 33 |
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy
|
Coudert, B.
|
|
|
23 |
2 |
p. 388-394
|
artikel
|
| 34 |
Survival from common and rare cancers in Germany in the early 21st century
|
Hiripi, E.
|
|
|
23 |
2 |
p. 472-479
|
artikel
|
| 35 |
Table of Contents
|
|
|
|
23 |
2 |
p. iv-vi
|
artikel
|
| 36 |
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results
|
Secondino, S.
|
|
|
23 |
2 |
p. 435-441
|
artikel
|
| 37 |
The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population
|
Yun, S.J.
|
|
|
23 |
2 |
p. 401-405
|
artikel
|
| 38 |
“The only thing I know is that I know nothing”: 5-fluorouracil in human milk
|
Peccatori, F.A.
|
|
|
23 |
2 |
p. 543-544
|
artikel
|
| 39 |
Toxicity burden score: a novel approach to summarize multiple toxic effects
|
Lee, S.M.
|
|
|
23 |
2 |
p. 537-541
|
artikel
|
| 40 |
Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989
|
Hollestein, L.M.
|
|
|
23 |
2 |
p. 524-530
|
artikel
|
| 41 |
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome
|
Yerushalmi, R.
|
|
|
23 |
2 |
p. 338-345
|
artikel
|
| 42 |
Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO)
|
Lortholary, A.
|
|
|
23 |
2 |
p. 346-352
|
artikel
|
Tijdschrift beschrijving